Bladder Cancer and Cancer Immunotherapy: A New Path Forward
New Cancer Specialists Join Johns Hopkins Kimmel Cancer Center
ESMO Virtual Congress 2020: Real-World Evidence of the Impact of Prior Autoimmune Disease on Immune Checkpoint Inhibitor Outcomes in Patients with Metastatic Urothelial Cancer
Dr. Jean Hoffman-Censits on the Results of a Phase II Trial Studying Atezolizumab in Bladder Cancer
Dr. Jean Hoffman-Censits on the Results of a Phase II Trial Studying Atezolizumab in Bladder Cancer
Improving Diagnosis and Treatment of Bladder Cancer
Atezolizumab generates excitement in advanced urothelial cancer | MDedge Hematology and Oncology
Bladder Cancer in Women: Improving Diagnosis and Treatment - Jean Hoffman- Censits
Dr. Hoffman-Censits Discusses the Future Treatment of Bladder Cancer
Jean Hoffman-Censits on Twitter: "Just wrapped a video with Armine Smith talking about the Women's Bladder Cancer Program - medical home at Sibley. More great things to come! #Bladdercancer https://t.co/7qtxVIW9qd" / Twitter
Jean Hoffman-Censits (@JCensits) / Twitter
PDF) Atezolizumab in patients with renal insufficiency and mixed variant histology: analyses from an expanded access program in platinum-treated locally advanced or metastatic urothelial carcinoma
Dr. Jean (Hoffman) Hoffman-Censits, MD – Baltimore, MD | Oncology
ESMO Virtual Congress 2020: Real-World Evidence of the Impact of Prior Autoimmune Disease on Immune Checkpoint Inhibitor Outcomes in Patients with Metastatic Urothelial Cancer
Dr. Jean Hoffman-Censits, MD | Baltimore, MD | Healthgrades
Jean Heather Hoffman-Censits, M.D., Assistant Professor of Oncology | Johns Hopkins Medicine
Jean HOFFMAN-CENSITS | Thomas Jefferson University, Philadelphia | Jefferson | Department of Medical Oncology
Jean Hoffman-Censits (@JCensits) / Twitter
1245480607 NPI Number | JEAN H. HOFFMAN-CENSITS MD | BALTIMORE, MD | NPI Registry | Medical Coding Library | www.HIPAASpace.com © 2022
100+ "Jean Hoffman" profiles | LinkedIn
Bladder Cancer and Cancer Immunotherapy: A New Path Forward
Jean Hoffman-Censits - Co-Director, Women's Bladder Cancer Program - Sidney Kimmel Cancer Center at Johns Hopkins | LinkedIn
Jefferson Health - On the blog: With Bladder Cancer Awareness Month coming up in May, we spoke with Dr. Jean Hoffman-Censits, M.D. Director of the Genitourinary Multidisciplinary Cancer Clinic Department of Medical
Jean Hoffman-Censits (@JCensits) / Twitter
